The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Szliter, E. A.
Right arrow Articles by Hazlett, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Szliter, E. A.
Right arrow Articles by Hazlett, L. D.
The Journal of Immunology, 2007, 178: 1105-1114.
Copyright © 2007 by The American Association of Immunologists, Inc.

Vasoactive Intestinal Peptide Balances Pro- and Anti-Inflammatory Cytokines in the Pseudomonas aeruginosa-Infected Cornea and Protects against Corneal Perforation1

Elizabeth A. Szliter, Shahrzad Lighvani, Ronald P. Barrett and Linda D. Hazlett2

Department of Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, MI 48201

Corneal infection with Pseudomonas aeruginosa perforates the cornea in susceptible C57BL/6 (B6), but not resistant BALB/c, mice. To determine whether vasoactive intestinal peptide (VIP) played a role in development of the resistant response, protein expression levels were tested by immunocytochemistry and enzyme immunoassay in BALB/c and B6 corneas. Both mouse strains showed constitutive expression of corneal VIP protein and nerve fiber distribution. However, disparate expression patterns were detected in the cornea after infection. VIP protein was elevated significantly in BALB/c over B6 mice at 5 and 7 days postinfection. Therefore, B6 mice were injected with rVIP and subsequently demonstrated decreased corneal opacity and resistance to corneal perforation compared with PBS controls. rVIP- vs PBS-treated B6 mice also demonstrated down-regulation of corneal mRNA and/or protein levels for proinflammatory cytokines/chemokines: IFN-{gamma}, IL-1beta, MIP-2, and TNF-{alpha}, whereas anti-inflammatory mediators, IL-10 and TGF-beta1, were up-regulated. Treatment with rVIP decreased NO levels and polymorphonuclear neutrophil (PMN) number. To further define the role of VIP, peritoneal macrophages (M{phi}) and PMN from BALB/c and B6 mice were stimulated with LPS and treated with rVIP. Treatment of LPS-stimulated M{phi} from both mouse strains resulted in decreased IL-1beta and MIP-2 protein levels; PMN responded similarly. Both cell types also displayed a strain-dependent differential response to rVIP, whereby B6 M{phi}/PMN responded only to a higher concentration of VIP compared with cells from BALB/c mice. These data provide evidence that neuroimmune regulation of the cytokine network and host inflammatory cells functions to promote resistance against P. aeruginosa corneal infection.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grants R01EY02986 and P30EY04068.

2 Address correspondence and reprint requests to Dr. Linda D. Hazlett, Department of Anatomy and Cell Biology, Wayne State University School of Medicine, 540 East Canfield Avenue, Detroit, MI 48201. E-mail address: lhazlett{at}med.wayne.edu

3 Abbreviations used in this paper: M{phi}, macrophage; PMN, polymorphonuclear neutrophil; VIP, vasoactive intestinal peptide; p.i., postinfection; MPO, myeloperoxidase; r.t., room temperature; MMLV, Moloney murine leukemia virus; EIA, enzyme immunoassay.


Related articles in The JI:

IN THIS ISSUE

The JI 2007 178: 639-640. [Full Text]  



This article has been cited by other articles:


Home page
IOVSHome page
Z. Zhou, R. P. Barrett, S. A. McClellan, Y. Zhang, E. A. Szliter, N. van Rooijen, and L. D. Hazlett
Substance P Delays Apoptosis, Enhancing Keratitis after Pseudomonas aeruginosa Infection
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4458 - 4467.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. A. McClellan, Y. Zhang, R. P. Barrett, and L. D. Hazlett
Substance P Promotes Susceptibility to Pseudomonas aeruginosa Keratitis in Resistant Mice: Anti-inflammatory Mediators Downregulated
Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1502 - 1511.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
E. Gonzalez-Rey, P. Anderson, and M. Delgado
Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy
Ann Rheum Dis, November 1, 2007; 66(suppl_3): iii70 - iii76.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. D. Hazlett, Q. Li, J. Liu, S. McClellan, W. Du, and R. P. Barrett
NKT Cells Are Critical to Initiate an Inflammatory Response after Pseudomonas aeruginosa Ocular Infection in Susceptible Mice
J. Immunol., July 15, 2007; 179(2): 1138 - 1146.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
L. Shen, S. Barabino, A. W. Taylor, and M. R. Dana
Effect of the Ocular Microenvironment in Regulating Corneal Dendritic Cell Maturation
Arch Ophthalmol, July 1, 2007; 125(7): 908 - 915.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.